Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Core Laboratories Inc. (CLB) Financial Statements

Core Laboratories Inc. (CLB) reported trailing twelve-month revenue of $519.2M (up 0.3% year on year) and net income of $24.4M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $10.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CLBCore Laboratories Inc.Follow CLB — free
Oil & Gas Equipment & Services · Energy
—
Price chart with a free account
Market cap
454.7M
P/E TTM
19.1
Dividend yield
0.4%
52-week
—
Next earnings
28 Oct, in 4 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.

LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Revenue509.8523.8526.5519.2
Gross profit109.8103.3108.9101.3
Operating income54.658.656.547.8
Pre-tax income41.246.245.936.8
Income tax4.214.015.512.1
Net income36.731.429.724.4
Diluted EPS ($)0.770.660.630.52
Diluted shares (mn)47.547.747.0—

USD millions · SEC XBRL

Core Laboratories Inc. — questions

What is Core Laboratories Inc.'s revenue?
$519.2M over the twelve months to 2026-06-30, up 0.3% year on year, from its 10-Q and 10-K filings.
What is Core Laboratories Inc.'s net income?
$24.4M over the twelve months to 2026-06-30.
What is Core Laboratories Inc.'s free cash flow?
$10.9M over the twelve months to 2026-06-30.
What are Core Laboratories Inc.'s diluted earnings per share?
$0.52 over the twelve months to 2026-06-30.

Every figure on this page comes from Core Laboratories Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.